Skip to main content
. 2023 Nov 22;98:104883. doi: 10.1016/j.ebiom.2023.104883

Fig. 2.

Fig. 2

Systemic (serum) levels of CXCL10 in SSc without ILD (N = 124), SSc-ILD (N = 41) and healthy controls (N = 13). Patients with SSc with or without interstitial lung disease have statistically significant higher CXCL10 levels compared to healthy controls (Mann–Whitney U test). Patients with SSc-ILD had statistically significant higher levels of CXCL10 compared to SSc without ILD (Mann–Whitney U test). Measurements are shown as median values (dashed) with IQR (dotted) in pg/ml.